International Law Office

Latest updates

Philip Jeyaretnam

Need for speed: get your anti-suit injunction fast!

Arbitration & ADR - Singapore
Dentons Rodyk

Parties entering into arbitration agreements ordinarily abide by their contractually chosen dispute resolution mechanism and proceed accordingly.

Fernando Eduardo Serec

Price of litigating in Brazil: court-awarded attorneys' fees

Litigation - Brazil
TozziniFreire Advogados

In addition to contractual fees, winning attorneys are entitled to court-awarded attorneys' fees, which are determined using objective criteria.

Arturo Sferruzza

Fine line between financial initiatives in PV greenhouses and genuine agricultural projects

Energy & Natural Resources - Italy
Norton Rose Fulbright Studio Legale

The Regional Administrative Court of Sardinia recently annulled the regional authority's decision to revoke authorisation for the construction and operation of a photovoltaic (PV) plant on the rooftops of agricultural greenhouses following its alleged loss of status as an agricultural company.

Will Pearce

Takeover Panel: roundup of recent panel statements

Corporate Finance/M&A - United Kingdom
Davis Polk & Wardwell LLP

The Takeover Panel recently published a revised version of the Takeover Code to reflect amendments relating to the response statement to its October 2018 consultation on asset valuations and the Financial Conduct Authority's announcement that it will phase out the United Kingdom Listing Authority name.

Abigail Smith

Court of Appeal dismisses appeal of judgment awarding Apotex damages

Healthcare & Life Sciences - Canada
Smart & Biggar/Fetherstonhaugh

In December 2017 Apotex was awarded more than C$11 million in damages and pre-judgment interest for losses resulting from delays in the US Food and Drug Administration's approval of its amoxicillin-clavulanic acid and levodopa-carbidopa products, which had been caused by contractual breaches and negligence on the part of MDS Pharma Services (MDS).

Abigail Smith

Federal Court finds invalidity allegations relating to patent for metformin formulations unjustified

Intellectual Property - Canada
Smart & Biggar/Fetherstonhaugh

Valeant Canada's application for an order prohibiting the minister of health from issuing a notice of compliance to Generic Partners for its generic version of Valeant's Glumetza, a metformin formulation, was recently granted.

OnDemand

1

Three’s a crowd? Third-party arbitration funding

Arbitration & ADR / Canada, Cyprus, Greece, India, Netherlands, Poland, United Kingdom

2

Uber-complex: regulating ride-hail services

Shipping & Transport / Finland, USA

3

Competition and antitrust in the digital age

Competition & Antitrust / Bulgaria, Czech Republic, European Union, Hungary, Mexico, Pakistan, Poland, Slovenia, Switzerland, Turkey